402 related articles for article (PubMed ID: 20808233)
1. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
[TBL] [Abstract][Full Text] [Related]
2. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
3. Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent.
Frinking PJ; Tardy I; Théraulaz M; Arditi M; Powers J; Pochon S; Tranquart F
Ultrasound Med Biol; 2012 Aug; 38(8):1460-9. PubMed ID: 22579540
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
[TBL] [Abstract][Full Text] [Related]
5. Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment.
Grouls C; Hatting M; Rix A; Pochon S; Lederle W; Tardy I; Kuhl CK; Trautwein C; Kiessling F; Palmowski M
Radiology; 2013 May; 267(2):487-95. PubMed ID: 23360735
[TBL] [Abstract][Full Text] [Related]
6. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor receptor 2-specific microbubbles for molecular ultrasound detection of prostate cancer in a rat model.
Fischer T; Thomas A; Tardy I; Schneider M; Hünigen H; Custodis P; Beyersdorff D; Plendl J; Schnorr J; Diekmann F; Gemeinhardt O
Invest Radiol; 2010 Oct; 45(10):675-84. PubMed ID: 20733504
[TBL] [Abstract][Full Text] [Related]
8. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.
Baetke SC; Rix A; Tranquart F; Schneider R; Lammers T; Kiessling F; Lederle W
Radiology; 2016 Feb; 278(2):430-40. PubMed ID: 26313618
[TBL] [Abstract][Full Text] [Related]
9. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study.
Smeenge M; Tranquart F; Mannaerts CK; de Reijke TM; van de Vijver MJ; Laguna MP; Pochon S; de la Rosette JJMCH; Wijkstra H
Invest Radiol; 2017 Jul; 52(7):419-427. PubMed ID: 28257340
[TBL] [Abstract][Full Text] [Related]
10. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft.
Sugimoto K; Moriyasu F; Negishi Y; Hamano N; Oshiro H; Rognin NG; Yoshida T; Kamiyama N; Aramaki Y; Imai Y
J Ultrasound Med; 2012 Dec; 31(12):1909-16. PubMed ID: 23197543
[TBL] [Abstract][Full Text] [Related]
11. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
Yuan Y; Liu Y; Zhu XM; Hu J; Zhao CY; Jiang F
J Ultrasound Med; 2019 Feb; 38(2):299-305. PubMed ID: 30027616
[TBL] [Abstract][Full Text] [Related]
12. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
[TBL] [Abstract][Full Text] [Related]
13. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).
Bzyl J; Lederle W; Rix A; Grouls C; Tardy I; Pochon S; Siepmann M; Penzkofer T; Schneider M; Kiessling F; Palmowski M
Eur Radiol; 2011 Sep; 21(9):1988-95. PubMed ID: 21562807
[TBL] [Abstract][Full Text] [Related]
14. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
[TBL] [Abstract][Full Text] [Related]
15. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
[TBL] [Abstract][Full Text] [Related]
16. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
17. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
18. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55.
Hackl C; Schacherer D; Anders M; Wiedemann LM; Mohr A; Schlitt HJ; Stroszczynski C; Tranquart F; Jung EM
Ultraschall Med; 2016 Jun; 37(3):290-6. PubMed ID: 27112624
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species.
Bettinger T; Bussat P; Tardy I; Pochon S; Hyvelin JM; Emmel P; Henrioud S; Biolluz N; Willmann JK; Schneider M; Tranquart F
Invest Radiol; 2012 Sep; 47(9):516-23. PubMed ID: 22814589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
